Targeting immune checkpoints in non small cell lung cancer
A Bianco, U Malapelle, D Rocco, F Perrotta… - Current Opinion in …, 2018 - Elsevier
Highlights•Oncogenic drivers and mechanisms of adaptive immunity are changing the
landscape of lung cancer treatment.•Cancers can disrupt cancer cell immune recognition by …
landscape of lung cancer treatment.•Cancers can disrupt cancer cell immune recognition by …
Targeting immune checkpoints in non small cell lung cancer
A Bianco, U Malapelle, D Rocco, F Perrotta… - CURRENT OPINION IN …, 2018 - iris.unimol.it
Cancers have the ability to disrupt immune response by interfering with adaptive immunity.
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Targeting immune checkpoints in non small cell lung cancer.
A Bianco, U Malapelle, D Rocco, F Perrotta… - Current Opinion in …, 2018 - europepmc.org
Cancers have the ability to disrupt immune response by interfering with adaptive immunity.
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Targeting immune checkpoints in non small cell lung cancer
A Bianco, U Malapelle, D Rocco… - CURRENT OPINION …, 2018 - iris.unicampania.it
Cancers have the ability to disrupt immune response by interfering with adaptive immunity.
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Targeting immune checkpoints in non small cell lung cancer
A Bianco, U Malapelle, D Rocco… - Current opinion in …, 2018 - pubmed.ncbi.nlm.nih.gov
Cancers have the ability to disrupt immune response by interfering with adaptive immunity.
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Targeting immune checkpoints in non small cell lung cancer.
A Bianco, U Malapelle, D Rocco, F Perrotta… - CURRENT OPINION IN …, 2018 - iris.unina.it
Cancers have the ability to disrupt immune response by interfering with adaptive immunity.
Blocking checkpoint pathways has become a target for pharmacological research in lung …
Blocking checkpoint pathways has become a target for pharmacological research in lung …